These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22971864)
1. Comparative study of effectiveness of oral acyclovir with oral erythromycin in the treatment of Pityriasis rosea. Amatya A; Rajouria EA; Karn DK Kathmandu Univ Med J (KUMJ); 2012; 10(37):57-61. PubMed ID: 22971864 [TBL] [Abstract][Full Text] [Related]
2. Use of high-dose acyclovir in pityriasis rosea. Drago F; Vecchio F; Rebora A J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis. Rodriguez-Zuniga M; Torres N; Garcia-Perdomo H An Bras Dermatol; 2018; 93(5):686-695. PubMed ID: 30156618 [TBL] [Abstract][Full Text] [Related]
4. Oral erythromycin is ineffective in the treatment of pityriasis rosea. Rasi A; Tajziehchi L; Savabi-Nasab S J Drugs Dermatol; 2008 Jan; 7(1):35-8. PubMed ID: 18246696 [TBL] [Abstract][Full Text] [Related]
5. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. Singh S; ; Tiwary NK Indian J Dermatol Venereol Leprol; 2016; 82(5):505-9. PubMed ID: 27212277 [TBL] [Abstract][Full Text] [Related]
6. Oral erythromycin is ineffective in the treatment of pityriasis rosea. Bukhari IA J Drugs Dermatol; 2008 Jul; 7(7):625. PubMed ID: 18664152 [No Abstract] [Full Text] [Related]
7. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. Sharma PK; Yadav TP; Gautam RK; Taneja N; Satyanarayana L J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):241-4. PubMed ID: 10642679 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis. Chang HC; Sung CW; Lin MH J Dermatolog Treat; 2019 May; 30(3):288-293. PubMed ID: 30109959 [TBL] [Abstract][Full Text] [Related]
9. A position statement on the management of patients with pityriasis rosea. Chuh A; Zawar V; Sciallis G; Kempf W J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1670-1681. PubMed ID: 27406919 [TBL] [Abstract][Full Text] [Related]
11. The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea. Ehsani A; Esmaily N; Noormohammadpour P; Toosi S; Hosseinpour A; Hosseini M; Sayanjali S Indian J Dermatol; 2010; 55(3):246-8. PubMed ID: 21063515 [TBL] [Abstract][Full Text] [Related]
14. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. Rassai S; Feily A; Sina N; Abtahian S J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):24-6. PubMed ID: 20477925 [TBL] [Abstract][Full Text] [Related]
16. Narrow band UVB phototherapy and oral acyclovir for pityriasis rosea. Chuh A Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):64-5. PubMed ID: 14738537 [No Abstract] [Full Text] [Related]
17. A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea. Ganguly S J Clin Diagn Res; 2014 May; 8(5):YC01-4. PubMed ID: 24995231 [TBL] [Abstract][Full Text] [Related]